Currently out of the existing stock ratings of Shaunak Deepak, 10 are a BUY (100%).

Shaunak Deepak

Work Performance Price Targets & Ratings Chart

Analyst Shaunak Deepak, Previously, Shaunak Deepak worked at JEFFERIES.

Shaunak Deepak’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on KPTI, Karyopharm Therapeutics at 17-Mar-2017.

Wall Street Analyst Shaunak Deepak

Analyst best performing recommendations are on MNKD (MANNKIND CORP).
MNKD MannKind Corp KPTI Karyopharm Therapeutics RIGL Rigel Pharmaceuticals SYBX Synlogic

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Oct-2019

$8

$4.76 (146.91%)

$11

1 days ago
(27-Feb-2026)

2/11 (18.18%)

$4.76 (146.91%)

848

Buy Since 23-Jul-2025

$3.5

$0.26 (8.02%)

$7.5

1 days ago
(27-Feb-2026)

0/5 (0%)

$0.26 (8.02%)

Buy Since 19-Dec-2024

$9

$5.76 (177.78%)

$10

3 months 4 days ago
(24-Nov-2025)

0/2 (0%)

$3.87 (75.44%)

Buy Since 27-Feb-2023

$15

$11.76 (362.96%)

$12

5 months 23 days ago
(05-Sep-2025)

2/5 (40%)

$9.46 (170.76%)

384

Buy Since 10-Oct-2023

$15

$11.76 (362.96%)

$10

5 months 23 days ago
(05-Sep-2025)

0/2 (0%)

$9.46 (170.76%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Shaunak Deepak?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?